Cytokine-induced Killer Study for Patients With Stage II Melanoma
Clinical trial NCT02498756 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT02498756
- Sponsor
- The First People's Hospital of Changzhou
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2038-08-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.